spacer
spacer
Trevigen
Shopping Cart Shopping Cart

spacer
spacer
spacer
Drop Down
Trevigen HomeCompanyProductsTechnical InformationDistributorSpacerLiterature
spacer
spacer
spacer
spacer
spacer
spacer
spacer
spacer


HT Fluorescent Homogeneous PARP Inhibition Assay

Trevigen's Homogeneous PARP Inhibition Assay is a highly sensitive fluorescent screening assay for the rapid identification of PARP-1 inhibitors in an in vitro system. This one hour endpoint assay is performed in two successive steps requiring only the consecutive addition of reaction components. A PARP reaction is first performed followed by a detection step. Inhibitors are identified by an increase in fluorescent signal when PARP mediated NAD+ depletion is inhibited. The level of NAD+ is coupled to a cycling assay involving alcohol dehydrogenase and diaphorase. Each time NAD+ cycles through these coupled reactions, a molecule of highly fluorescent resorufin is generated. Alcohol dehydrogenase (AD) reduces NAD+ to NADH, while the diaphorase cycles NADH back to NAD+ with the generation of a highly fluorescent resorufin molecule (from the non-fluorescent substrate, resazurin). The number of cycles can be controlled by the time of incubation to adjust assay sensitivity, as needed, and the reaction is terminated by the addition of a stop solution. In addition, the assay can be used to determine relative IC50 values for PARP inhibitors and is capable of detecting as little as 10% inhibition of PARP-1 activity. The Homogeneous PARP Inhibition Assay is designed for the screening of PARP inhibitors using a NAD concentration below the Km of PARP. Once potential inhibitors are identified, results can be confirmed using Trevigen's HT Universal PARP Assay kits (cat# 4676-096-K or 4677-096-K).

Features:
  • Fluorescent, non-radioactive format
  • High throughput 96 test size
  • Detects as little as 10% inhibition of PARP-1 activity
  •  
    Applications: Identification of PARP-1 inhibitors
     
    Components: Part # Component Size
      4690-096-01 10X Cycling Enzymes 600 µl
      4690-096-02 200 nM NAD 3.5 ml
      4690-096-03 PARP HSA Enzyme 200 ng/µl 100 µl
      4690-096-04 Activated DNA, 200 ng/µl 600 µl
      4690-096-05 Resazurin 600 µl
      4690-096-06 10X Buffer (1M Tris-HCl, pH 8) 3.5 ml
      4690-096-07 Stop Solution 6 ml
     
    Storage: Components are stored at -20°C and Room Temperature
     
    References: 1. Meyer-Ficca, M.L., et al., Poly(ADP-ribose) polymerases: managing genome stability. Int J Biochem Cell Biol, 2005. 37(5): p. 920-6.
    2. Hassa, P.O., et al., Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev, 2006. 70(3): p. 789-829.
    3. Virag, L. and C. Szabo, The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev, 2002. 54(3): p. 375-429.
    Top


     
    Ordering Information
    spacer
    Catalog #: Price:

    4690-096-K
    HT F Homogeneous PARP Inhibition Assay,
    96 Tests
    $450.00
    Add to Cart

    Trevigen Products are now available for ordering through

    - AND -


    Download Protocol
    data icon

    Download Worksheet
    Work Sheet

    Related Products

    HT Chemiluminescent PARP/Apoptosis Assay

    HT Colorimetric PARP/Apoptosis Assay

    HT Chemiluminescent PARG Assay Kit

    HT Colorimetric PARG Assay Kit

    Universal Colorimetric PARP Assay Kit

    Universal Chemiluminescent PARP Assay Kit

    PARP Inhibitors

    TREVIGEN INC. :: 8405 HELGERMAN CT. :: GAITHERSBURG, MD 20877
    1.800.TREVIGEN :: 1.800.873.8443 :: (FAX) 1.301.560.4973 :: INFO@TREVIGEN.COM :: SITE MAP